Cargando…

CMTM8 inhibits the carcinogenesis and progression of bladder cancer

Bladder cancer is the most common tumor of the urinary tract. The incidence of bladder cancer has increased in the last few decades, thus novel molecular markers for early diagnosis and more efficacious treatment are urgently needed. Chemokine-like factor (CKLF)-like MARVEL transmembrane domain cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	GAO, DENGHUI, HU, HAO, WANG, YING, YU, WEIDONG, ZHOU, JIANHUA, WANG, XIAOFENG, WANG, WEIPING, ZHOU, CHUNYAN, XU, KEXIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722886/ https://www.ncbi.nlm.nih.gov/pubmed/26503336 http://dx.doi.org/10.3892/or.2015.4310

Ejemplares similares

CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
por: Chen, Zhao-Hui, et al.
Publicado: (2023)

CMTM3 as a Potential New Immune Checkpoint Regulator
por: Shen, Qian, et al.
Publicado: (2022)

CMTM6 knockdown prevents glioma progression by inactivating the mTOR pathway
por: Wei, Li, et al.
Publicado: (2022)

Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
por: Xue, Hui, et al.
Publicado: (2022)

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)

MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4
por: Zhang, Hongxia, et al.
Publicado: (2015)

CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis
por: Shi, Weidong, et al.
Publicado: (2021)

Clinical significance of CMTM4 expression in hepatocellular carcinoma
por: Bei, Chunhua, et al.
Publicado: (2017)

CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer
por: Su, Yu, et al.
Publicado: (2014)

Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5
por: Buscham, Tobias J, et al.
Publicado: (2022)

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022)

Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
por: Kang, Ning, et al.
Publicado: (2022)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
por: Song, Xin, et al.
Publicado: (2021)

CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
por: Li, Jie, et al.
Publicado: (2022)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
por: Takeuchi, Hiroto, et al.
Publicado: (2020)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

AB179. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells
por: Hu, Fengzhan, et al.
Publicado: (2015)

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
por: Huang, Yue, et al.
Publicado: (2022)

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021)

Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2021)

Expression of CMTM4 shows clinical significance in lung cancer
por: Zhu, Xiaonian, et al.
Publicado: (2020)

CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value
por: Wu, Jie, et al.
Publicado: (2020)

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration
por: Li, Shoubin, et al.
Publicado: (2022)

Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders
por: Chen, Shu, et al.
Publicado: (2020)

Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis
por: Lu, Chong, et al.
Publicado: (2021)

CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Li, Zesong, et al.
Publicado: (2014)

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
por: Wang, Hanfeng, et al.
Publicado: (2022)

Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
por: Shi, Shuai, et al.
Publicado: (2022)

CMTM6 as a candidate risk gene for cervical cancer: Comprehensive bioinformatics study
por: Huang, Xiaoting, et al.
Publicado: (2022)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
por: Tan, Shengkui, et al.
Publicado: (2022)

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma
por: Pei, Yulin, et al.
Publicado: (2023)

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma
por: Li, Ting, et al.
Publicado: (2015)

CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer
por: Zhou, Zixuan, et al.
Publicado: (2021)

Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model
por: Fernandes, João C., et al.
Publicado: (2012)

Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
por: Long, Yiru, et al.
Publicado: (2023)

Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer
por: Yin, Bo, et al.
Publicado: (2022)

CMTM5 inhibits renal cancer cell growth through inducing cell-cycle arrest and apoptosis
por: Cai, Bing, et al.
Publicado: (2017)

Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment
por: Zhao, Yanbin, et al.
Publicado: (2021)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
por: Huang, Xiaoting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ueutvjh9evkhaqbo256hhro1m4